# Erregierre S.p.A., San Paolo d'Argon, Italy – FDA Inspections

Source: https://www.keypedia.com/companies/erregierre-spa/b911826f-b82b-46c8-a7cb-68206ff19d2e

> Inspection records and compliance data for Erregierre S.p.A. in San Paolo d'Argon. 5 FDA inspections on record, last inspected March 14, 2025.

---

## Details

- Name: Erregierre S.p.A.
- FEI Number: 3002806924
- Business Operations: API MANUFACTURE
- Address Line 1: Via Francesco Baracca 19
- City: San Paolo d'Argon
- Country Name: Italy
- Address: Via Francesco Baracca 19, San Paolo d'Argon, Italy
- Country: Italy

## Related Documents

- [FDA Inspection 1265603 - Erregierre S.p.A. - 2025-03-14](https://www.keypedia.com/records/fda_inspections/erregierre-spa/c6f95fbd-bea1-410c-8d8c-b049d3feebab) — source: FDA, date: March 14, 2025
- FDA Inspection 1265603 - Erregierre S.p.A. - 2025-03-14 — source: FDA, date: March 14, 2025
- FDA Inspection 1265603 - Erregierre S.p.A. - 2025-03-14 — classification: No Action Indicated (NAI), source: FDA, date: March 14, 2025
- FDA Inspection 1265603 - Erregierre S.p.A. - 2025-03-14 — classification: No Action Indicated (NAI), source: FDA, date: March 14, 2025
- FDA Inspection 1100563 - Erregierre S.p.A. - 2019-07-26 — classification: No Action Indicated (NAI), source: FDA, date: July 26, 2019
- FDA Inspection 1100563 - Erregierre S.p.A. - 2019-07-26 — classification: No Action Indicated (NAI), source: FDA, date: July 26, 2019
- FDA Inspection 961493 - Erregierre S.p.A. - 2016-02-12 — classification: No Action Indicated (NAI), source: FDA, date: February 12, 2016
- FDA Inspection 961493 - Erregierre S.p.A. - 2016-02-12 — classification: No Action Indicated (NAI), source: FDA, date: February 12, 2016
- FDA Inspection 811583 - Erregierre S.p.A. - 2012-11-16 — classification: No Action Indicated (NAI), source: FDA, date: November 16, 2012
- FDA Inspection 666157 - Erregierre S.p.A. - 2010-05-20 — classification: No Action Indicated (NAI), source: FDA, date: May 20, 2010

## Related Companies

- [Hovione PharmaScience Limited](https://www.keypedia.com/companies/hovione-pharmascience-limited/cb368750-5a82-4f5e-b5b8-d7469313f8fd)
- [Quimica Sintetica, SA](https://www.keypedia.com/companies/quimica-sintetica-sa/7a7011c6-9eca-44b0-8eb0-95d8e1f6c1b7)
- [Ajinomoto Omnichem NV](https://www.keypedia.com/companies/ajinomoto-omnichem-nv/d532956d-2064-4475-8034-a651dc7c2bc9)
- [Minakem Beuvry Production SAS](https://www.keypedia.com/companies/minakem-beuvry-production-sas/8fb2d8e7-cb14-4356-8902-bb679852c669)
- [AGC Pharma Chemicals Europe, S.L.U.](https://www.keypedia.com/companies/agc-pharma-chemicals-europe-slu/e6912c0d-c34a-4c03-bbc8-e02054d135e5)
- [Xellia (Taizhou) Pharmaceuticals](https://www.keypedia.com/companies/xellia-taizhou-pharmaceuticals/d0debe75-9c46-480f-a6b6-4695ad2bb771)
- [Evonik Corporation](https://www.keypedia.com/companies/evonik-corporation/5f1fa8da-b68a-4d31-bbfa-2aba62e8a4d1)
- [Cosma SPA](https://www.keypedia.com/companies/cosma-spa/14f96eaf-912e-4eed-af27-43ec40d9b7b7)
- [Dottikon Exclusive Synthesis AG](https://www.keypedia.com/companies/dottikon-exclusive-synthesis-ag/db7bdf8b-bd88-416f-94f2-62f946e90074)
- [Siegfried AG](https://www.keypedia.com/companies/siegfried-ag/f8cbd6d0-c948-4640-9f46-3c91206aae2a)